Clinical Trial Update: Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Patients With Strabismus [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of GSK1358820 (botulinum toxin type A) for strabismus. The study is completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Strabismus

Drugs mentioned

• GSK1358820

Snippet

Sponsor: GlaxoSmithKline | Conditions: Strabismus | Phase 3 | Status: COMPLETED | Results posted: 2014-08-01